Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs61055315 | chr2:237536156 | C/T | 1.11E-16 | 170 | 25.17 | 24.77 | 3.17 | KM Plot |
PCPG | rs61112574 | chr13:37537635 | G/GC | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs61130265 | chr1:40519399 | A/G | 0.000312 | 175 | 25.2 | 27.78 | 25.17 | KM Plot |
PCPG | rs61169668 | chr1:36579763 | CA/C | 4.26E-11 | 176 | 10.3 | 25.67 | 25.08 | KM Plot |
PCPG | rs61274064 | chr3:80570169 | AAAAACAG/A | 6.03E-5 | 178 | 19.53 | 24.03 | 27.23 | KM Plot |
PCPG | rs61284811 | chr16:87331146 | G/A | 0 | 175 | 21.55 | 31.9 | 2.22 | KM Plot |
PCPG | rs61313276 | chr12:6592257 | A/AT | 0.000283 | 176 | 16.3 | 26.27 | 25.42 | KM Plot |
PCPG | rs61338787 | chr12:56695460 | G/GT | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs61345371 | chr1:36922605 | T/C | 8.27E-5 | 176 | 25.4 | 26.62 | 10.3 | KM Plot |
PCPG | rs6150584 | chr8:53836130 | A/ATAAATATAAGTTCTTCT | 0.000375 | 175 | 24.7 | 27.33 | 6.1 | KM Plot |
PCPG | rs61519033 | chr10:50528029 | G/A | 4.05E-6 | 175 | 24.85 | 33.13 | 25.17 | KM Plot |
PCPG | rs61615335 | chr3:80558979 | CTGAAG/C | 2.79E-5 | 177 | 19.53 | 24.77 | 27.2 | KM Plot |
PCPG | rs61616786 | chr7:158701181 | G/A | 0 | 177 | 25.53 | 23.43 | 3.17 | KM Plot |
PCPG | rs61623705 | chr10:29844494 | G/A | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs61707903 | chr2:176200596 | TG/T | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |